These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22572996)

  • 41. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.
    Palomba S; Russo T; Orio F; Falbo A; Manguso F; Cascella T; Tolino A; Carmina E; Colao A; Zullo F
    Hum Reprod; 2006 Feb; 21(2):457-65. PubMed ID: 16253975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.
    Oktenli C; Ozgurtas T; Dede M; Sanisoglu YS; Yenen MC; Yesilova Z; Kenar L; Kurt YG; Baser I; Smith J; Cianflone K
    Gynecol Endocrinol; 2007 Dec; 23(12):710-5. PubMed ID: 18075846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
    Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
    Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin reduces abortion in pregnant women with polycystic ovary syndrome.
    Khattab S; Mohsen IA; Foutouh IA; Ramadan A; Moaz M; Al-Inany H
    Gynecol Endocrinol; 2006 Dec; 22(12):680-4. PubMed ID: 17162710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
    Mioni R; Chiarelli S; Xamin N; Zuliani L; Granzotto M; Mozzanega B; Maffei P; Martini C; Blandamura S; Sicolo N; Vettor R
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4089-96. PubMed ID: 15292352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J; Starczewski A
    Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
    Nawaz FH; Rizvi J
    Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
    Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
    Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
    Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
    Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Chen HF; Kuo JJ; Ho HN; Yang YS; Chen SU
    Hum Reprod; 2010 Mar; 25(3):779-85. PubMed ID: 20093255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.